Vol. 57 No. 5 (2018): Acta Oncologica

Articles

• Unilateral hippocampal wasting after combined-modality therapy for glioblastoma

  Tyler M. Seibert, Yoseph Dalia, Roshan Karunamuni, David Piccioni, Carrie R. McDonald, Nikdokht Farid, Jona A. Hattangadi-Gluth

  688-691

  Published: 2018-05-04

  • PDF

• Primary bone lymphoma presenting as skeletal lesions in a patient recently treated for prostate cancer

  Maximilian Kordes, Jeffrey Yachnin

  700-703

  Published: 2018-05-04

  • PDF

• Dose painting of prostate cancer based on Gleason score correlations with apparent diffusion coefficients

  Eric Grönlund, Silvia Johansson, Tufve Nyholm, Camilla Thellenberg, Anders Ahnesjö

  574-581

  Published: 2018-05-04

  • PDF

• Male breast cancer: a nation-wide population-based comparison with female breast cancer

  Marianne D. Lautrup, Signe S. Thorup, Vibeke Jensen, Susanne Bokmand, Karen Haugaard, Inger Hoejris, Anne-Marie B. Jylling, Hjoerdis Joernsgaard, Giedrius Lelkaitis, Mette H. Oldenburg, Gro M. Qvamme, Katrine Soee, Peer Christiansen

  613-621

  Published: 2018-05-04

  • PDF

• Risk factors for impaired pulmonary function and cardiorespiratory fitness in very long-term adult survivors of childhood acute lymphoblastic leukemia after treatment with chemotherapy only*

  Ole Henrik Myrdal, Adriani Kanellopoulos, Jon R. Christensen, Ellen Ruud, Elisabeth Edvardsen, Johny Kongerud, Liv Ingunn Sikkeland, May B. Lund

  658-664

  Published: 2018-05-04

  • PDF

• The volume of PET-defined, active bone marrow spared predicts acute hematologic toxicities in anal cancer patients receiving concurrent chemoradiotherapy

  Christopher Freese, Mickaela Sudhoff, Luke Lewis, Michael Lamba, Jordan Kharofa

  683-686

  Published: 2018-05-04

  • PDF

• Author’s response to Porter and Keefe letter to the editor regarding ‘new frontiers in couple-based interventions in cancer care: refining the prescription for spousal communication’

  Hoda Badr

  695-697

  Published: 2018-05-04

  • PDF

• Eruptive cherry angiomas developing in a patient treated with ramucirumab

  Pablo Espinosa Lara, Camino Medina-Puente, Alejandro Riquelme Oliveira, José Jiménez-Reyes

  709-711

  Published: 2018-05-04

  • PDF

• A new approach for modeling patient overall radiosensitivity and predicting multiple toxicity endpoints for breast cancer patients

  Chamberlain Mbah, Kim De Ruyck, Silke De Schrijver, Charlotte De Sutter, Kimberly Schiettecatte, Chris Monten, Leen Paelinck, Wilfried De Neve, Hubert Thierens, Catharine West, Gustavo Amorim, Olivier Thas, Liv Veldeman

  604-612

  Published: 2018-05-04

  • PDF

• Clinical efficacy and safety of a highly conformal, supine, hybrid forward and inverse planned intensity modulated radiation therapy technique for craniospinal irradiation

  Safia K. Ahmed, Jon J. Kruse, Thomas B. Bradley, Chris J. Beltran, Nadia N. Issa Laack

  629-636

  Published: 2018-05-04

  • PDF

• Determinants of variable resource use for multidisciplinary team meetings in cancer care

  Nathalie Alexandersson, Linn Rosell, Jessica Wihl, Björn Ohlsson, Katarina Steen Carlsson, Mef Nilbert

  675-680

  Published: 2018-05-04

  • PDF

• Proton therapy in stage II–IV non-small cell lung cancer: pattern of care and impact on trial accrual

  He J. Zhu, Romaine C. Nichols Jr., Randal H. Henderson, Christopher G. Morris, Dat C. Pham, Lisa Jones, Bradford S. Hoppe

  692-693

  Published: 2018-05-04

  • PDF

• Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report

  Abdul Rafeh Naqash, Li V. Yang, Edward J. Sanderlin, Druid C. Atwell, Paul R. Walker

  705-708

  Published: 2018-05-04

  • PDF

• Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual health

  Clement K. Ho, Curtis M. Bryant, Nancy P. Mendenhall, Randal H. Henderson, William M. Mendenhall, Romaine C. Nichols, Christopher G. Morris, Dvaraju Kanmaniraja, Derek J. Hamlin, Zuofeng Li, Bradford S. Hoppe

  582-588

  Published: 2018-05-04

  • PDF

• Health-related quality of life in different states of breast cancer – comparing different instruments

  Mervi Rautalin, Niilo Färkkilä, Harri Sintonen, Tiina Saarto, Kimmo Taari, Tiina Jahkola, Risto P. Roine

  622-628

  Published: 2018-05-04

  • PDF

• Information needs of survivors and families after childhood CNS tumor treatment: a population-based study

  Emma Hovén, Birgitta Lannering, Göran Gustafsson, Krister K. Boman

  649-657

  Published: 2018-05-04

  • PDF

• Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus

  Cansu G. Genç, Heinz-Josef Klümpen, Timm Denecke, Bertram Wiedenmann, Marianne Pavel

  686-688

  Published: 2018-05-04

  • PDF

• Pain relief after a short course of palliative radiotherapy in pancreatic cancer, the Academic Medical Center (AMC) experience

  Gati Ebrahimi, Coen R. N. Rasch, Geertjan van Tienhoven

  697-700

  Published: 2018-05-04

  • PDF

• A review of plan library approaches in adaptive radiotherapy of bladder cancer

  Shane D. Collins, Michelle M. Leech

  566-573

  Published: 2018-05-04

  • PDF

• Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer

  Annelie Augustinsson, Carolina Ellberg, Ulf Kristoffersson, Åke Borg, Håkan Olsson

  595-603

  Published: 2018-05-04

  • PDF

• Outcomes following proton therapy for pediatric ependymoma

  Daniel J. Indelicato, Julie A. Bradley, Ronny L. Rotondo, Ronica H. Nanda, Natalie Logie, Eric S. Sandler, Philipp R. Aldana, Nathan J. Ranalli, Alexandra D. Beier, Christopher G. Morris, Nancy P. Mendenhall

  644-648

  Published: 2018-05-04

  • PDF

• Pseudoprogression on bevacizumab treatment: tumor-dynamics in the modern era of systemic treatment for metastatic colorectal cancer

  Cornelis J. A. Punt, Joost Huiskens, Thomas van Gulik, Marc Engelbrecht

  681-682

  Published: 2018-05-04

  • PDF

• Couple-based communication interventions for cancer: moving beyond a ‘one size fits all’ approach

  Laura S. Porter, Francis J. Keefe

  693-695

  Published: 2018-05-04

  • PDF

• Non-cirrhotic portal hypertension associated with multicentric Castleman’s disease: a case report

  Ana Luísa Pinto, Marília Gomes, Maria Augusta Cipriano, Maria Letícia Ribeiro

  703-705

  Published: 2018-05-04

  • PDF

• A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1

  Frede Donskov, Niels Viggo Jensen, Torben Smidt-Hansen

  589-594

  Published: 2018-05-04

• Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014

  Paul M. Jeene, Kim C. de Vries, Johanna G. H. van Nes, Johannes J. M. Kwakman, Gerda Wester, Tom Rozema, Pètra M. Braam, Jaap D. Zindler, Peter Koper, Joost J. Nuyttens, Hanneke A. Vos-Westerman, Ilona Schmeets, Charles G. H. J. Niël, Stefan Hutschemaekers, Yvette M. van der Linden, Joost J. C. Verhoeff, Lukas J. A. Stalpers

  637-643

  Published: 2018-05-04

  • PDF

• Bone mineral density is compromised in very long-term survivors of irradiated childhood brain tumor

  Tiina M. Remes, Pekka M. Arikoski, Päivi M. Lähteenmäki, Mikko O. Arola, Tytti M.-L. Pokka, V. Pekka Riikonen, Kirsti H. Sirkiä, Heikki M. J. Rantala, Arja H. Harila-Saari, Marja K. Ojaniemi

  665-674

  Published: 2018-05-04

  • PDF